3rd Quarter - Report

RUBICON ADVISORS, LLC for WATSON PHARMACEUTICALS INC

Firm
Client
Income
$98,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029

LobbyistCovered position, as disclosed
WILLIAM BURKE —
KATHY KULKARNI —
TODD SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (112th), H.R. 1432 (112th), H.R. 2100 (112th), H.R. 5629 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.